Prognostic Value of CA 19-9 in a Phase I/II Trial of Dose Escalated Intensity Modulated Radiation Therapy (IMRT) With Concurrent Full-dose Gemcitabine (G) in Unresectable Pancreatic Cancer

被引：0
|
作者：
Vainshtein, J. M. [1 ]
Schipper, M. [1 ]
Zalupski, M. [1 ]
Lawrence, T. S. [1 ]
Abrams, R. [2 ]
Francis, I. R. [1 ]
Leslie, W. [2 ]
Ben-Josef, E. [3 ]
机构：
[1] Univ Michigan Hlth Syst, Ann Arbor, MI USA
[2] Rush Presbyterian St Lukes Med Ctr, Chicago, IL USA
[3] Univ Penn, Philadelphia, PA 19104 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 84卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2012.07.378
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S146 / S147
页数：2
相关论文
共 50 条
  • [1] Prognostic Significance of Carbohydrate Antigen 19-9 in Unresectable Locally Advanced Pancreatic Cancer Treated With Dose-Escalated Intensity Modulated Radiation Therapy and Concurrent Full-Dose Gemcitabine: Analysis of a Prospective Phase 1/2 Dose Escalation Study
    Vainshtein, Jeffrey M.
    Schipper, Matthew
    Zalupski, Mark M.
    Lawrence, Theodore S.
    Abrams, Ross
    Francis, Isaac R.
    Khan, Gazala
    Leslie, William
    Ben-Josef, Edgar
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (01): : 96 - 101
  • [2] Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine
    Allen, AM
    Zalupski, MM
    Robertson, JM
    Eckhauser, FE
    Simone, D
    Brown, D
    Hejna, G
    Normolle, D
    Lawrence, TS
    McGinn, CJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (05): : 1461 - 1467
  • [3] A Phase I/II Trial of Intensity Modulated Radiation (IMRT) Dose Escalation With Concurrent Fixed-dose Rate Gemcitabine (FDR-G) in Patients With Unresectable Pancreatic Cancer
    Ben-Josef, Edgar
    Schipper, Mathew
    Francis, Isaac R.
    Hadley, Scott
    Ten-Haken, Randall
    Lawrence, Theodore
    Normolle, Daniel
    Simeone, Diane M.
    Sonnenday, Christopher
    Abrams, Ross
    Leslie, William
    Khan, Gazala
    Zalupski, Mark M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (05): : 1166 - 1171
  • [4] A phase I trial of full-dose gemcitabine, oxaliplatin, and radiation therapy for unresectable pancreatic cancer: Preliminary analysis
    Feng, F. Y.
    Griffith, K. A.
    Murphy, J. D.
    Francis, I. R.
    Desai, S. P.
    Lawrence, T. S.
    Zalupski, M. M.
    Ben-Josef, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S308 - S309
  • [5] A phase II trial of full-dose gemcitabine with concurrent radiation therapy in patients with resectable or unresectable non-metastatic pancreatic cancer
    Small, W.
    Talamonti, M.
    Normolle, D.
    Freedman, G.
    Berlin, J.
    Kinsella, T.
    Philip, P.
    Zalupski, M.
    Mulcahy, M.
    Meropol, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S172 - S173
  • [6] Phase I/II Radiation Dose-Escalation Trial of Intensity Modulated Radiotherapy (IMRT) with Concurrent Fixed Dose-Rate Gemcitabine (FDR-G) for Unresectable Pancreatic Cancer
    Ben-Josef, E.
    Schipper, M.
    Francis, I.
    Khan, G.
    Hadley, S.
    Lawrence, T.
    Simeone, D.
    Abrams, R.
    Sonnenday, C.
    Zalupski, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S127 - S128
  • [7] Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: A multicenter phase II trial
    Small, William, Jr.
    Berlin, Jordan
    Freedman, Gary M.
    Lawrence, Theodore
    Talamonti, Mark S.
    Mulcahy, Mary F.
    Chakravarthy, A. Bapsi
    Konski, Andre A.
    Zalupski, Mark M.
    Philip, Philip A.
    Kinsella, Timothy J.
    Merchant, Nipun B.
    Hoffman, John P.
    Benson, Al B.
    Nicol, Steven
    Xu, Rong M.
    Gill, John F.
    McGinn, Cornelius J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (06) : 942 - 947
  • [8] Phase I study of oxaliplatin, full-dose gemcitabine, and concurrent radiation therapy in pancreatic cancer
    Desai, Sameer P.
    Ben-Josef, Edgar
    Normolle, Daniel P.
    Francis, Isaac R.
    Greenson, Joel K.
    Simeone, Diane M.
    Chang, Alfred E.
    Colletti, Lisa M.
    Lawrence, Theodore S.
    Zalupski, Mark M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (29) : 4587 - 4592
  • [9] Radiation Therapy With Full-Dose Gemcitabine and Oxaliplatin for Unresectable Pancreatic Cancer
    Hunter, Klaudia U.
    Feng, Felix Y.
    Griffith, Kent A.
    Francis, Isaac R.
    Lawrence, Theodore S.
    Desai, Sameer
    Murphy, James D.
    Zalupski, Mark M.
    Ben-Josef, Edgar
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (03): : 921 - 926
  • [10] Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer
    McGinn, CJ
    Zalupski, MM
    Shureiqi, I
    Robertson, JM
    Eckhauser, FE
    Smith, DC
    Brown, D
    Hejna, G
    Strawderman, M
    Normolle, D
    Lawrence, TS
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (22) : 4202 - 4208
12345